Accumulation of advanced glycation end products in women with preeclampsia: Possible involvement of placental oxidative and nitrative stress

Placenta

Volumn 27, Issue 2-3, 2006, Pages 225-233

  Chekir, C ^a   Nakatsuka, Mikiya ^a   Noguchi, S ^a   Konishi, H ^a   Kamada, Y ^a   Sasaki, A ^a   Hao, L ^a   Hiramatsu, Y ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

4 Hydroxy 2 nonenal; 8 Hydroxy 2 deoxyguanosine; Advanced glycation end product; Nitroguanosine; Nitrotyrosine; Placenta; Preeclampsia

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER; DNA; LIPID; REACTIVE NITROGEN SPECIES;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OXIDATIVE STRESS; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; STATISTICAL ANALYSIS; UPREGULATION; WESTERN BLOTTING;

ADULT; ALDEHYDES; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; DEOXYGUANOSINE; DNA; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REACTIVE NITROGEN SPECIES; TYROSINE;

EID: 28844443590     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2005.02.016     Document Type: Article

References (54)

1. M. Brownlee A. Cerami H. Vlassara Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N Engl J Med 318 1988 315-321
2. H. Vlassara M. Brownlee K.R. Manogue C.A. Dinarello A. Pasagian Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling Science 240 1988 546-548
3. M. Kirstein J. Brett S. Radoff S. Ogawa D. Stern H. Vlassara Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging Proc Natl Acad Sci U S A 87 1990 9010-9014
4. A.M. Schmidt O. Hori J. Brett S.D. Yan J.L. Wautier D. Stern Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions Arterioscler Thromb 14 1994 1521-1528
5. C. Cerami H. Founds I. Nicholl T. Mitsuhashi D. Giordano S. Vanpatten et al. Tobacco smoke is a source of toxic reactive glycation products Proc Natl Acad Sci U S A 94 1997 13915-13920
6. J. Rodriguez-Garcia J.R. Requena S. Rodriguez-Segade Increased concentrations of serum pentosidine in rheumatoid arthritis Clin Chem 44 1998 250-255
7. S. Ligier P.R. Fortin M.M. Newkirk A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE Br J Rheumatol 37 1998 1307-1314
8. I.D. Nicholl R. Bucala Advanced glycation end products and cigarette smoking Cell Mol Biol 44 1998 1025-1033
9. A.M. Schmidt S.-D. Yan J.L. Wautier D.M. Stern Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis Circ Res 84 1999 489-497
10. A.K. Mohamed A. Bierhaus S. Schiekofer H. Tritschler R. Ziegler P.P. Nawroth The role of oxidative stress and NF-κB activation in late diabetic complications Biofactors 10 1999 157-167
11. A.M. Schmidt S.-D. Yan S.-F. Yan D.M. Stern The biology of the receptor for advanced glycation end products and its ligands Biochim Biophys Acta 1498 2000 99-111
12. R. Singh A. Barden T. Mori L. Beilin Advanced glycation end-products: A review Diabetologia 44 2001 129-146
13. A.M. Schmidt M. Hasu D. Popov J.H. Zhang J. Chen S.D. Yan et al. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins Proc Natl Acad Sci U S A 91 1994 8807-8811
14. ε-carboxymethyl lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression J Biol Chem 274 1999 31740-31749
15. H. Vlassara The AGE-receptor in the pathogenesis of diabetic complications Diabetes Metab Res Rev 17 2001 436-443
16. N. Shanmugam Y.S. Kim L. Lanting R. Natarajan Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products J Biol Chem 278 2003 34834-34844
17. M.A. Hofmann S. Drury C. Fu W. Qu A. Taguchi Y. et al. Lu RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/ calgranulin polypeptides Cell 97 1999 889-901
18. A.M. Schmidt S.D. Yan S.F. Yan D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J Clin Invest 108 2001 949-955
19. G. Munch M. Gerlach J. Sian A. Wong P. Riederer Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress? Ann Neurol 44 1988 S85-S88
20. H. Konishi M. Nakatsuka C. Chekir S. Noguchi Y. Kamada A. Sasaki et al. Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts Hum Reprod 19 2004 2156-2162
21. I.A. Buhimschi G.R. Saade K. Chwalisz R.E. Garfield The nitric oxide pathway in pre-eclampsia: Pathophysiological implications Hum Reprod Update 4 1998 25-42
22. T.H. Hung J.N. Skepper D.S. Charnock-Jones G.J. Burton Hypoxia-reoxygenation: A potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia Circ Res 90 2002 1274-1281
23. M. Nakatsuka M. Takata K. Tada K. Asagiri T. Habara S. Noguchi et al A long-term transdermal nitric oxide donor improves uteroplacental circulation in women with preeclampsia J Ultrasound Med 21 2002 831-836
24. M. Nakatsuka M. Takata K. Tada T. Kudo Effect of a nitric oxide donor on the ophthalmic artery flow velocity waveform in preeclamptic women J Ultrasound Med 21 2002 309-313
25. M. Takata M. Nakatsuka T. Kudo Differential blood flow in uterine, ophthalmic, and brachial arteries of preeclamptic women Obstet Gynecol 100 2002 931-939
26. R.E. Little B.C. Gladen Levels of lipid peroxides in uncomplicated pregnancy: A review of the literature Reprod Toxicol 13 1999 347-352
27. Y. Takagi T. Nikaido T. Toki N. Kita M. Kanai T. Ashida et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction Virchows Arch 444 2004 49-55
28. M. Nakatsuka K. Asagiri Y. Kimura Y. Kamada K. Tada T. Kudo Generation of peroxynitrite and apoptosis in placenta of patients with chorioamnionitis: Possible implications in placental abruption Hum Reprod 14 1999 1101-1106
29. L. Myatt W. Kossenjans R. Sahay A. Eis D. Brockman Oxidative stress causes vascular dysfunction in the placenta J Matern Fetal Med 9 2000 79-82
30. S. Morikawa O. Kurauchi M. Tanaka M. Yoneda K. Uchida A. Itakura et al. Increased mitochondrial damage by lipid peroxidation in trophoblast cells of preeclamptic placentas Biochem Mol Biol Int 41 1997 767-775
31. E. Shibata K. Ejima H. Nanri N. Toki C. Koyama M. Ikeda et al. Enhanced protein levels of protein thiol/disulphide oxidoreductases in placentae from pre-eclamptic subjects Placenta 22 2001 566-572
32. D.I. Santoso P. Rogers E.M. Wallace U. Manuelpillai D. Walker S.B. Subakir Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae Placenta 23 2002 373-379
33. R.G. Knowles M. Merrett M. Salter S. Moncada Differential induction of brain, lung, and liver nitric oxide synthase by endotoxin in the rat Biochem J 270 1990 833-836
34. T. Mitsuhashi H. Vlassara H.W. Founds Y.M. Li Standardizing the immunological measurement of advanced glycation endproducts using normal human serum J Immunol Methods 207 1997 79-88
35. M. Nakatsuka K. Nakatsuka Y. Osawa Metabolism-based inactivation of penile nitric oxide synthase activity by guanabenz Drug Metab Dispos 26 1998 497-501
36. Y. Kamada M. Nakatsuka K. Asagiri S. Noguchi T. Habara M. Takata et al. GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis Hum Reprod 15 2000 2512-2519
37. M. Nakatsuka K. Asagiri S. Noguchi T. Habara T. Kudo Nafamostat mesilate, a serine protease inhibitor, suppresses lipopolysaccharide-induced nitric oxide synthesis and apoptosis in cultured human trophoblasts Life Sci 67 2000 1243-1250
38. K. Asagiri M. Nakatsuka H. Konishi S. Noguchi M. Takata T. Habara et al. Involvement of peroxynitrite in LPS-induced apoptosis of trophoblasts J Obstet Gynaecol Res 29 2003 49-55
39. L. Myatt Role of placenta in preeclampsia Endocrine 19 2002 103-111
40. H. Kuniyasu Y. Chihara H. Kondo Differential effects between amphoterin and advanced glycation end products on colon cancer cells Int J Cancer 104 2003 722-727
41. A. Bierhaus S. Chevion M. Chevion M. Hofmann P. Quehenberger T. Illmer et al. Advanced glycation end product-induced activation of NF-κB is suppressed by α-lipoic acid in cultured endothelial cells Diabetes 46 1997 1481-1490
42. C. Loske A. Neumann A.M. Cunningham K. Nichol R. Schinzel P. Riederer et al. Cytotoxicity of advanced glycation end products is mediated by oxidative stress J Neural Transm 105 1998 1005-1015
43. A. Neumann R. Schinzel D. Palm P. Riederer G. Munch High molecular weight hyaluronic acid inhibits advanced glycation end product-induced NF-κB activation and cytokine expression FEBS Lett 453 1999 283-287
44. C. Loske A. Gerdemann W. Schepl M. Wycislo R. Schinzel D. Palm et al. Transition metal-mediated glycoxidation accelerates cross-linking of β-amyloid peptide Eur J Biochem 267 2000 4171-4178
45. H. Sugimoto K. Shikata J. Wada S. Horiuchi H. Makino Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: Aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli Diabetologia 42 1999 878-886
46. L. Myatt R.B. Rosenfield A.L. Eis D.E. Brockman I. Greer F. Lyall Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action Hypertension 28 1996 488-493
47. A. Many C.A. Hubel S.J. Fisher J.M. Roberts Y. Zhou Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia Am J Pathol 156 2000 321-331
48. J. Stanek A.L. Eis L. Myatt Nitrotyrosine immunostaining correlates with increased extracellular matrix: Evidence of postplacental hypoxia Placenta 22 Suppl A 2001 S56-S62
49. A.M. Roggensack Y. Zhang S.T. Davidge Evidence for peroxynitrite formation in the vasculature of women with preeclampsia Hypertension 33 1999 83-89
50. W. Kossenjans A. Eis R. Sahay D. Brockman L. Myatt Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia Am J Physiol Heart Circ Physiol 278 2000 H1311-H1319
51. T. Akaike S. Okamoto T. Sawa J. Yoshitake F. Tamura K. Ichimori et al. 8-Nitroguanosine formation in viral pneumonia and its implication for pathogenesis Proc Natl Acad Sci U S A 100 2003 685-690
52. T. Sawa T. Akaike K. Ichimori T. Akuta K. Kaneko H. Nakayama et al. Superoxide generation mediated by 8-nitroguanosine, a highly redox-active nucleic acid derivative Biochem Biophys Res Commun 311 2003 300-306
53. L.L. Wu C.C. Chiou P.Y. Chang J.T. Wu Urinary 8-OHdG: A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics Clin Chim Acta 339 2004 1-9
54. C.L. Cooke J.C. Brockelsby P.N. Baker S.T. Davidge The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia Hypertens Pregnancy 22 2003 173-184